Possible problem with optipen pro-1 - Should diabetic patients continue to use this product?

Basit Öğe Kaydı
dc.contributor.authorGoksen, Damla
dc.contributor.authorDarcan, Sukran
dc.contributor.authorBuyukinan, Muanimer
dc.contributor.authorKurt, Emine
dc.date.accessioned2019-10-27T19:17:53Z
dc.date.available2019-10-27T19:17:53Z
dc.date.issued2006
dc.departmentEge Üniversitesien_US
dc.identifier.doi10.2337/dc06-0605en_US
dc.identifier.endpage1711en_US
dc.identifier.issn0149-5992
dc.identifier.issue7en_US
dc.identifier.pmid16801608en_US
dc.identifier.startpage1710en_US
dc.identifier.urihttps://doi.org/10.2337/dc06-0605
dc.identifier.urihttps://hdl.handle.net/11454/38495
dc.identifier.volume29en_US
dc.identifier.wosWOS:000238854000046en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAmer Diabetes Assocen_US
dc.relation.ispartofDiabetes Careen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titlePossible problem with optipen pro-1 - Should diabetic patients continue to use this product?en_US
dc.typeLetteren_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu